EUVIMEDEUVIMED entdecken
Editorial

Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities

Mazie Tsang iD, Thomas W LeBlanc iD

JCO Oncology Practice · 2024

DOI: 10.1200/op.24.00081 ↗

Kurz gefasst

Editorial in der Zeitschrift JCO Oncology Practice, 2024. Verfasst von Mazie Tsang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic, Phoenix, AZ. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Terminal Care, Palliative Care. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

@JCOOP_ASCO editorial on unique needs of end-of-life care for different blood cancers discusses: #pallheme improves QOL but less utilized in cancers. Contextualize Weisse et al study. More #pallheme research needed for lymphoma and myeloma in era of cell therapy

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsTerminal CarePalliative CareHumansQuality of Life

Autor:innen und Institutionen

  • Mayo Clinic, Phoenix, AZ.
  • Duke Cancer Institute, Durham, NC.

ORCID-Profile: Mazie Tsang, Thomas W LeBlanc

Zitieren

APA

Tsang, M., & LeBlanc, T. W. (2024). Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncology Practice. https://doi.org/10.1200/op.24.00081

Vancouver

Tsang M, LeBlanc TW. Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities. JCO Oncology Practice. 2024. doi:10.1200/op.24.00081

BibTeX
@article{Tsang2024,
  author = {Tsang, Mazie and LeBlanc, Thomas W},
  title = {Palliative and End-of-Life Care in Hematologic Malignancies: Progress and Opportunities},
  journal = {JCO Oncology Practice},
  year = {2024},
  doi = {10.1200/op.24.00081}
}
Kostenlos starten →